Beyond AD and PN: Expanding Horizons for Interleukin-31 Blockade in Treatment-Refractory Pruritus Have you read this article from the JDD? Interleukin-31 receptor alpha targeting has established its place in our…
Read More
Curated by the JDD Editors Missed any of our October highlights? September is our Atopic Dermatitis issue and is packed with intriguing articles, and you’ll want to start to dive…
Read More
Beyond Single Target Topicals: Rethinking Atopic Dermatitis Management Have you read this article from the JDD? Managing atopic dermatitis remains a complex clinical challenge, particularly when standard single-target topical agents…
Read More
Navigating Atopic Dermatitis: Pathophysiology, Targeted Therapeutics, and Patient Perspectives Atopic dermatitis is one of the most commonly treated conditions in dermatology. While previous treatments revolved around optimizing sensitive skincare regimens…
Read More
From the Vault: Expert Recommendations on Microbiome Balance, Secondary Infections, and Therapeutic Gaps Managing atopic dermatitis (AD) involves navigating a complex interplay between skin barrier dysfunction and microbial dysbiosis. As…
Read More
Rapid Itch Relief in Eczema: New JDD Data on Moisturizer and Cream Performance This is a must-read article from JDD for dermatologists and dermatology healthcare professionals following the day-to-day management…
Read More
Promising efficacy and tolerability in this small cohort of patients with treatment-resistant AD Dual Therapy for Atopic Dermatitis: Lebrikizumab and JAK Inhibitors Used in Tandem for Treatment-Resistant Cases from the…
Read More
JDD analysis highlights racial gaps in JAK inhibitor dermatology trials Have you caught this new JDD, analysis on JAK inhibitor trials? Dermatologists and clinical investigators will likely find this review relevant…
Read More
Early clinical mapping of exosome therapies in dermatology points to promise and questions Have you seen this JDD article on exosome-based dermatologic therapies? A scoping review summarized human clinical work…
Read More
Have you read this JDD consensus on advanced topical nonsteroidal therapies for atopic dermatitis? Dive into this recent article from the March issue! A seven-dermatologist expert panel used a structured…
Read More
From the Vault: A popular consensus paper recommends newborn‑to‑child barrier care with ceramide‑containing moisturizers to delay flares and reduce steroid need We pulled this widely read JDD article because it…
Read More
Breakthroughs in atopic dermatitis are redefining treatment from the inside out. Discover how new data on race, microbes, and patient preferences are transforming the way we think about AD. In…
Read More
